Cary Street Partners’s Stryker SYK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.08M Sell
9,767
-32
-0.3% -$10.1K 0.07% 275
2026
Q1
$3.22M Sell
9,799
-66
-0.7% -$23.7K 0.08% 247
2025
Q4
$3.47M Buy
9,865
+2,045
+26% +$745K 0.09% 230
2025
Q3
$2.89M Sell
7,820
-182
-2% -$70.3K 0.08% 264
2025
Q2
$3.17M Sell
8,002
-290
-3% -$108K 0.09% 238
2025
Q1
$3.09M Sell
8,292
-123
-1% -$46.8K 0.1% 214
2024
Q4
$3.03M Buy
+8,415
New +$3.12M 0.1% 207

Other funds holding SYK

Cary Street Partners's SYK Position: Q2 2026 in Review

Cary Street Partners reduced its Stryker (SYK) stake by 0.33% in Q2 2026, selling an estimated $10.1K and leaving 9,767 shares worth $3.08M. The position accounts for 0.07% of the portfolio, ranked #275.

Cary Street Partners first reported a position in SYK in Q4 2024 and has held it in 7 quarters since. The position peaked at $3.47M in Q4 2025. 788 funds tracked by Wall St. Rank hold SYK as of Q2 2026.

  • Cary Street Partners held 9,767 shares of Stryker worth $3.08M as of Q2 2026.
  • Cary Street Partners sold 32 Stryker shares in Q2 2026, an estimated $10.1K.
  • Stryker made up 0.07% of Cary Street Partners's portfolio in Q2 2026, its #275 holding.
  • Cary Street Partners first reported a position in Stryker in Q4 2024 and has held it in 7 quarters since.
  • Cary Street Partners's Stryker position peaked at $3.47M in Q4 2025.
  • 788 funds tracked by Wall St. Rank held Stryker as of Q2 2026.

Based on Cary Street Partners's 13F filing for Q2 2026, filed 17 Jul 2026.